June 16, 2022
UNC Contribution to Gene Therapy in Hemophilia Highlighted by Endeavors Magazine
“A gene therapy clinical trial for hemophilia shows promise and could be approved by the FDA later this year — a feat made possible, in part, by UNC-Chapel Hill’s 70-year-old research program.” Click here to read the article.